Company Innoveren Scientific Inc.
Equities
IVRN
US4041243076
Advanced Medical Equipment & Technology
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.02 USD | -33.33% | -28.57% | -82.76% |
Business Summary
Sales per Business
USD in Million | 2021 | Weight | 2022 | Weight | Delta |
---|---|---|---|---|---|
Biologics and Therapeutic Device Incubator
100.0
%
| 2 | 100.0 % | 0 | 100.0 % | -71.86% |
Sales per region
USD in Million | 2021 | Weight | 2022 | Weight | Delta |
---|---|---|---|---|---|
United States
100.0
%
| 2 | 100.0 % | 0 | 100.0 % | -71.86% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 53 | 19-01-07 | |
Jeremy Daniel
DFI | Director of Finance/CFO | 48 | 19-02-03 |
Tanya Rhodes
CTO | Chief Tech/Sci/R&D Officer | 64 | 20-06-14 |
William E. Horne
BRD | Director/Board Member | 70 | 18-10-08 |
Jason Assad
IRC | Investor Relations Contact | - | - |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 65 | 22-01-16 | |
Chief Executive Officer | 53 | 19-01-07 | |
William E. Horne
BRD | Director/Board Member | 70 | 18-10-08 |
Chairman | 77 | 19-01-07 | |
Matthew Anderer
BRD | Director/Board Member | 59 | 22-01-16 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 712,710 | 253,876 ( 35.62 %) | 0 | 35.62 % |
Company contact information
Sector
1st Jan change | Capi. | |
---|---|---|
-82.76% | 107K | |
+8.35% | 209B | |
+9.41% | 175B | |
+11.75% | 131B | |
+19.34% | 99.98B | |
-0.84% | 61.12B | |
+15.08% | 52.34B | |
-2.10% | 46.5B | |
+0.10% | 39.24B | |
+11.50% | 38.47B |
- Stock Market
- Equities
- IVRN Stock
- Company Innoveren Scientific Inc.